resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases knee injury and Osteoarthritis Outcome Score (KOOS)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“In Table 2, the administration of resveratrol improves significantly (P < 0.05) both KOOS and WOMAC total scores at the end of the treatment, compared with baseline values and those reported in the control group postintervention.”
Quoted verbatim from Correlation between serum pro inflammatory cytokines and clinical scores of knee osteoarthritic patients using resveratrol as a supplementary therapy with meloxicam.. - Study
- RCT
- Duration
- 3 months
- Dose
- 500 mg/day
- Population
- Adults with painful knee osteoarthritis; resveratrol 500 mg/day plus meloxicam 15 mg/day versus placebo capsule plus meloxicam 15 mg/day (meloxicam in both arms)
Correlation between serum pro inflammatory cytokines and clinical scores of knee osteoarthritic patients using resveratrol as a supplementary therapy with meloxicam.2021PMID:34414904Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Knee injury and Osteoarthritis Outcome Score (KOOS)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PCZSSVXDE78EGHE42ZDWS3